You are invited to the upcoming NBD Seminar: iPSCs-based Regenerative Medicine and Drug Development of CNS Disorders.
Abstract:
iPSC technology has multiple applications in regenerative medicine and drug development. NS/PCs derived from iPSCs have shown promise for the treatment of spinal cord injury (SCI). We performed the first human participant transplantation of iPSC-derived NS/PCs for subacute SCI in 2021. iPSC-based techniques also offer new opportunities for disease modeling and drug development. Ropinirole was identified as a potential anti-ALS drug through iPSC-based studies and confirmed in the ROPALS trial.
Presenter:
Prof Hideyuki Okano
Professor and Chair
Department of Physiology
Keio University School of Medicine, Japan
Seminar Details:
Date: 22 June 2023, Thursday
Time: 3:00pm to 4:00pm
Venue:
Level 2, Amphitheatre, Duke-NUS
Host:
Prof Wang Hongyan
Principal Investigator & Deputy Programme Director
Neuroscience & Behavioural Disorders Programme
Duke-NUS
All are welcome. No registration is required.
.jpg)
